Add environmental-toxin overlay on the PD pathways
Browse filespd_toxin_target.parquet (79 toxin-gene rows) and pd_toxin_pathway.parquet (76 pathways with toxin evidence rolled up), plus card sections covering the EC mapping, specificity weighting and the direction-of-effect caveat.
- README.md +119 -2
- pd_toxin_pathway.parquet +3 -0
- pd_toxin_target.parquet +3 -0
README.md
CHANGED
|
@@ -6,6 +6,7 @@ tags:
|
|
| 6 |
- aidd
|
| 7 |
- knowledge-graph
|
| 8 |
- parkinsons-disease
|
|
|
|
| 9 |
pretty_name: Biopharma hackathon data
|
| 10 |
configs:
|
| 11 |
- config_name: targets
|
|
@@ -24,6 +25,10 @@ configs:
|
|
| 24 |
data_files: pd_subgraph_enrichment.parquet
|
| 25 |
- config_name: pd_tree
|
| 26 |
data_files: pd_tree.parquet
|
|
|
|
|
|
|
|
|
|
|
|
|
| 27 |
---
|
| 28 |
|
| 29 |
# Biopharma hackathon data
|
|
@@ -33,9 +38,10 @@ and nothing joins them:
|
|
| 33 |
|
| 34 |
1. **[GenomeScreen (relational)](#1-genomescreen-as-a-relational-dataset)** — 5 tables, the
|
| 35 |
DrugCLIP genome-wide virtual screen parsed into parquet.
|
| 36 |
-
2. **[Parkinson's disease subgraph](#2-parkinsons-disease-subgraph-primekg)** —
|
| 37 |
pathway-centric neighbourhood extracted from PrimeKG, as a graph and as a
|
| 38 |
-
disease→pathway→protein→drug tree
|
|
|
|
| 39 |
|
| 40 |
---
|
| 41 |
|
|
@@ -153,6 +159,8 @@ enrichment table for filtering it down.
|
|
| 153 |
| `pd_subgraph.parquet` | 162,384 | edge (both orientations — see below) |
|
| 154 |
| `pd_subgraph_enrichment.parquet` | 283 | pathway |
|
| 155 |
| `pd_tree.parquet` | 54,557 | root→leaf path, disease → pathway → protein → drug |
|
|
|
|
|
|
|
| 156 |
|
| 157 |
## How it was built
|
| 158 |
|
|
@@ -244,6 +252,65 @@ carry two relation types (usually enzyme + target), so they appear as two rows.
|
|
| 244 |
The tree drops `protein_protein` and `pathway_pathway`, which have no place in a tree; use
|
| 245 |
`pd_subgraph.parquet` for those.
|
| 246 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 247 |
## Caveats worth knowing before you use it
|
| 248 |
|
| 249 |
- **Every edge in `pd_subgraph.parquet` appears twice.** PrimeKG stores undirected edges in
|
|
@@ -265,6 +332,39 @@ The tree drops `protein_protein` and `pathway_pathway`, which have no place in a
|
|
| 265 |
protein interactions, not compounds with a PD rationale. Weight by target specificity, or
|
| 266 |
restrict to a pathway you care about, before reading anything into the ordering.
|
| 267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 268 |
## Usage
|
| 269 |
|
| 270 |
```python
|
|
@@ -294,6 +394,17 @@ conn.execute(f"""
|
|
| 294 |
WHERE drug_relation = 'target' AND pathway_qvalue < 0.05
|
| 295 |
GROUP BY 1 ORDER BY pathways DESC, proteins DESC LIMIT 25
|
| 296 |
""").fetchall()
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 297 |
```
|
| 298 |
|
| 299 |
## Source and license
|
|
@@ -305,6 +416,12 @@ the data itself, which is distributed via Harvard Dataverse
|
|
| 305 |
own ~20 constituent primary sources. Check those before redistributing. The `license` field in
|
| 306 |
this repo's metadata (CC-BY-4.0) describes the GenomeScreen tables above.
|
| 307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 308 |
> Chandak, P., Huang, K., Zitnik, M. *Building a knowledge graph to enable precision medicine.*
|
| 309 |
> Nature Scientific Data 10, 67 (2023).
|
| 310 |
|
|
|
|
| 6 |
- aidd
|
| 7 |
- knowledge-graph
|
| 8 |
- parkinsons-disease
|
| 9 |
+
- toxicology
|
| 10 |
pretty_name: Biopharma hackathon data
|
| 11 |
configs:
|
| 12 |
- config_name: targets
|
|
|
|
| 25 |
data_files: pd_subgraph_enrichment.parquet
|
| 26 |
- config_name: pd_tree
|
| 27 |
data_files: pd_tree.parquet
|
| 28 |
+
- config_name: pd_toxin_target
|
| 29 |
+
data_files: pd_toxin_target.parquet
|
| 30 |
+
- config_name: pd_toxin_pathway
|
| 31 |
+
data_files: pd_toxin_pathway.parquet
|
| 32 |
---
|
| 33 |
|
| 34 |
# Biopharma hackathon data
|
|
|
|
| 38 |
|
| 39 |
1. **[GenomeScreen (relational)](#1-genomescreen-as-a-relational-dataset)** — 5 tables, the
|
| 40 |
DrugCLIP genome-wide virtual screen parsed into parquet.
|
| 41 |
+
2. **[Parkinson's disease subgraph](#2-parkinsons-disease-subgraph-primekg)** — 5 tables, a
|
| 42 |
pathway-centric neighbourhood extracted from PrimeKG, as a graph and as a
|
| 43 |
+
disease→pathway→protein→drug tree, plus an environmental-toxin overlay on the same
|
| 44 |
+
pathways.
|
| 45 |
|
| 46 |
---
|
| 47 |
|
|
|
|
| 159 |
| `pd_subgraph.parquet` | 162,384 | edge (both orientations — see below) |
|
| 160 |
| `pd_subgraph_enrichment.parquet` | 283 | pathway |
|
| 161 |
| `pd_tree.parquet` | 54,557 | root→leaf path, disease → pathway → protein → drug |
|
| 162 |
+
| `pd_toxin_target.parquet` | 79 | (environmental toxin, gene) |
|
| 163 |
+
| `pd_toxin_pathway.parquet` | 76 | pathway, with toxin evidence rolled up |
|
| 164 |
|
| 165 |
## How it was built
|
| 166 |
|
|
|
|
| 252 |
The tree drops `protein_protein` and `pathway_pathway`, which have no place in a tree; use
|
| 253 |
`pd_subgraph.parquet` for those.
|
| 254 |
|
| 255 |
+
## The environmental-toxin overlay
|
| 256 |
+
|
| 257 |
+
A second, independent line of evidence on the same pathways. Ten environmental toxins with
|
| 258 |
+
an established PD association (paraquat, rotenone, MPTP, manganese, lead, mercury,
|
| 259 |
+
chlorpyrifos, dieldrin, trichloroethylene, tetrachloroethylene) were mapped to their
|
| 260 |
+
literature-co-mentioned gene targets, and those genes joined onto the tree's pathways.
|
| 261 |
+
|
| 262 |
+
The premise: a toxin that is *causative* for PD implicates the pathways it perturbs, so a
|
| 263 |
+
pathway reached by both the disease-association route and the toxicological route carries a
|
| 264 |
+
stronger prior than either alone. **9 of the 21 enriched pathways contain a toxin target**,
|
| 265 |
+
and the top of that list is the canonical PD tox story.
|
| 266 |
+
|
| 267 |
+
`pd_toxin_target.parquet` is one row per (toxin, gene): `toxin`, `cid`, `pubmed_mentions`,
|
| 268 |
+
`gene_symbol`, `protein_index` (PrimeKG), `evidence_count`, `n_source_entries`,
|
| 269 |
+
`source_entries`, `mapping_confidence`, `toxin_mapped_fraction`, `in_pd_tree`, `is_pd_seed`,
|
| 270 |
+
`tf`, `idf`, `specificity_weight`.
|
| 271 |
+
|
| 272 |
+
`pd_toxin_pathway.parquet` rolls that up per pathway and joins to `pd_tree.parquet` on
|
| 273 |
+
`pathway_index`: `n_toxins`, `n_toxin_targets`, `toxin_support`, `toxins`, `toxin_targets`,
|
| 274 |
+
alongside the pathway's `pathway_qvalue`, `n_drugs` and `n_target_drugs`.
|
| 275 |
+
|
| 276 |
+
Ranked by toxin support among pathways at q < 0.05:
|
| 277 |
+
|
| 278 |
+
| pathway | support | q | toxins | targets |
|
| 279 |
+
| --- | ---: | ---: | ---: | --- |
|
| 280 |
+
| Detoxification of Reactive Oxygen Species | 3.28 | 1.5e-02 | 6 | CAT, GPX1–3, SOD1–3 |
|
| 281 |
+
| Transcriptional activation of mitochondrial biogenesis | 2.99 | 2.4e-02 | 7 | GABPA, PPARGC1B, SOD2 |
|
| 282 |
+
| FOXO-mediated transcription of oxidative stress genes | 1.98 | 3.3e-02 | 6 | CAT, SOD2 |
|
| 283 |
+
| Interleukin-4 and Interleukin-13 signaling | 1.24 | 6.4e-03 | 4 | AKT1, BCL2, IL6, MAOA, TNF |
|
| 284 |
+
| Catecholamine biosynthesis | 1.05 | 1.6e-02 | 2 | TH |
|
| 285 |
+
| Biogenic amines deaminated by MAOA and MAOB | 0.19 | 6.4e-03 | 1 | MAOA, MAOB |
|
| 286 |
+
|
| 287 |
+
### How the targets were mapped
|
| 288 |
+
|
| 289 |
+
The source lists targets as `name [TAG] (count)`, where TAG is a gene symbol *or* an EC
|
| 290 |
+
number. Three properties of that format shape the table:
|
| 291 |
+
|
| 292 |
+
- **The EC entries carry the mechanism.** MPTP's causal target is monoamine oxidase, which
|
| 293 |
+
appears only as `EC:1.4.3.4`; rotenone's is complex I, only as `EC:1.6.99.3`. Symbol-only
|
| 294 |
+
parsing loses both. EC classes are expanded through a hand-curated map, and
|
| 295 |
+
`mapping_confidence` records how firm each expansion is: `exact` (one human gene),
|
| 296 |
+
`family` (a small enumerated family — MAOA/MAOB, SOD1–3), or `complex` (complex I core
|
| 297 |
+
subunits). Large cross-species classes (`peroxidase`, `unspecific monooxygenase`) and
|
| 298 |
+
non-human ones (photosystem II, lignin peroxidase, bacterial dehalogenases) are dropped
|
| 299 |
+
rather than guessed at.
|
| 300 |
+
- **A toxin often lists one protein twice**, once by symbol and once by EC — lead has both
|
| 301 |
+
`catalase [CAT] (576)` and `catalase [EC:1.11.1.6] (234)`. Rows are aggregated to the
|
| 302 |
+
(toxin, gene) grain and the counts summed; `source_entries` preserves what contributed.
|
| 303 |
+
A family EC has its evidence split across members rather than replicated, so a family tag
|
| 304 |
+
cannot outvote a specific symbol.
|
| 305 |
+
- **The gene lists are cross-species.** Influenza PB2, bacterial MERA, rice LOC4326471 and a
|
| 306 |
+
*Drosophila* GABA receptor all appear. Only symbols resolving to a PrimeKG `gene/protein`
|
| 307 |
+
node are kept.
|
| 308 |
+
|
| 309 |
+
`specificity_weight` is `tf × idf`: a gene's share of its toxin's mapped evidence, damped by
|
| 310 |
+
how many toxins name it. CAT and the SODs appear for 6 of the 10 toxins — they are the
|
| 311 |
+
background of the toxicology literature, not a toxin-specific signal, and the weighting is
|
| 312 |
+
what keeps them from dominating.
|
| 313 |
+
|
| 314 |
## Caveats worth knowing before you use it
|
| 315 |
|
| 316 |
- **Every edge in `pd_subgraph.parquet` appears twice.** PrimeKG stores undirected edges in
|
|
|
|
| 332 |
protein interactions, not compounds with a PD rationale. Weight by target specificity, or
|
| 333 |
restrict to a pathway you care about, before reading anything into the ordering.
|
| 334 |
|
| 335 |
+
- **PrimeKG's drug nodes are all of DrugBank, and it carries no approval status.** Every
|
| 336 |
+
`drug_id` is a `DB…` accession, but the set includes experimental entries, cofactors and
|
| 337 |
+
crystallographic ligands — NADH, copper and glutathione adducts all appear as `target`
|
| 338 |
+
drugs. There is no column to filter on; join against a DrugBank approval list if you need
|
| 339 |
+
approved compounds only.
|
| 340 |
+
|
| 341 |
+
Specific to the toxin overlay:
|
| 342 |
+
|
| 343 |
+
- **A shared target does not mean a shared direction of effect, and PrimeKG cannot tell you
|
| 344 |
+
which.** `drug_relation` distinguishes target from enzyme, never agonist from antagonist.
|
| 345 |
+
If a toxin causes PD by inhibiting a protein, a drug that also inhibits it is a risk, not a
|
| 346 |
+
therapy. `SLC6A3` is the clearest case: DAT-mediated uptake is how MPP+ enters dopaminergic
|
| 347 |
+
neurons, so a DAT blocker is protective while amphetamine — on the same target list — is
|
| 348 |
+
not. Read the overlay as nominating *pathways*, and get direction from DrugBank's action
|
| 349 |
+
field before selecting compounds within one.
|
| 350 |
+
- **The counts are literature co-mentions, not affinities or assays.** A high count means the
|
| 351 |
+
toxin and the gene are frequently discussed together, which tracks how well-studied a gene
|
| 352 |
+
is at least as much as how relevant it is.
|
| 353 |
+
- **The source lists only the top 8 of 25 targets per toxin.** Document frequencies — and so
|
| 354 |
+
every `idf` — are computed over that truncated view, which biases `idf` upward for genes
|
| 355 |
+
that fall below the cut for some toxins.
|
| 356 |
+
- **Two toxins are mostly unmappable.** `toxin_mapped_fraction` is 0.38 for tetrachloroethylene
|
| 357 |
+
and 0.40 for trichloroethylene; the rest of their lists is bacterial or fungal. Because `tf`
|
| 358 |
+
is a share of *mapped* evidence, the survivors absorb the whole share and their weights are
|
| 359 |
+
inflated. Treat anything below ~0.5 as soft.
|
| 360 |
+
- **`toxin_support` is a raw sum, so it rewards large pathways.** Unfiltered, `Neutrophil
|
| 361 |
+
degranulation` (478 proteins, q = 0.21) tops the ranking. The enrichment q-value already
|
| 362 |
+
controls for size — filter on it first, then rank by support.
|
| 363 |
+
- **10 toxin targets are absent from the tree entirely**, including all seven complex I core
|
| 364 |
+
subunits — the most PD-relevant mechanism in the set. They resolve to valid PrimeKG
|
| 365 |
+
`protein_index` values but sit in no PD-bridged pathway, so they contribute nothing to
|
| 366 |
+
`pd_toxin_pathway.parquet`. Filter `in_pd_tree = false` to see them.
|
| 367 |
+
|
| 368 |
## Usage
|
| 369 |
|
| 370 |
```python
|
|
|
|
| 394 |
WHERE drug_relation = 'target' AND pathway_qvalue < 0.05
|
| 395 |
GROUP BY 1 ORDER BY pathways DESC, proteins DESC LIMIT 25
|
| 396 |
""").fetchall()
|
| 397 |
+
|
| 398 |
+
# convergent evidence: drugs targeting proteins in pathways that are both
|
| 399 |
+
# statistically enriched for PD proteins and hit by a PD-associated toxin
|
| 400 |
+
conn.execute(f"""
|
| 401 |
+
SELECT t.drug_name, t.protein_name, x.pathway_name,
|
| 402 |
+
x.toxins, x.toxin_support, x.pathway_qvalue
|
| 403 |
+
FROM '{base}/pd_tree.parquet' t
|
| 404 |
+
JOIN '{base}/pd_toxin_pathway.parquet' x USING (pathway_index)
|
| 405 |
+
WHERE t.drug_relation = 'target' AND x.pathway_qvalue < 0.05
|
| 406 |
+
ORDER BY x.toxin_support DESC, t.drug_name
|
| 407 |
+
""").fetchall()
|
| 408 |
```
|
| 409 |
|
| 410 |
## Source and license
|
|
|
|
| 416 |
own ~20 constituent primary sources. Check those before redistributing. The `license` field in
|
| 417 |
this repo's metadata (CC-BY-4.0) describes the GenomeScreen tables above.
|
| 418 |
|
| 419 |
+
The toxin overlay adds a second source: the toxin list and its gene targets come from
|
| 420 |
+
**PubChem** (compound records and their literature-co-mentioned genes) and PubMed mention
|
| 421 |
+
counts, retrieved via the PubChem PUG-REST API. PubChem aggregates from many depositors whose
|
| 422 |
+
individual terms vary; see https://www.ncbi.nlm.nih.gov/home/about/policies/. The EC-to-gene
|
| 423 |
+
map and the specificity weighting are original to this dataset.
|
| 424 |
+
|
| 425 |
> Chandak, P., Huang, K., Zitnik, M. *Building a knowledge graph to enable precision medicine.*
|
| 426 |
> Nature Scientific Data 10, 67 (2023).
|
| 427 |
|
pd_toxin_pathway.parquet
ADDED
|
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
version https://git-lfs.github.com/spec/v1
|
| 2 |
+
oid sha256:92109720302c81997dbb3e65595a030303872618270b5e447fcb7e4ba1be98fb
|
| 3 |
+
size 8426
|
pd_toxin_target.parquet
ADDED
|
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
version https://git-lfs.github.com/spec/v1
|
| 2 |
+
oid sha256:679966d87a76403c24a67b1c6751f15d9d6dc58c883059f97dbde09991b2c2db
|
| 3 |
+
size 8037
|